Metacel Pharms Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for METACEL PHARMS LLC
METACEL PHARMS LLC has one approved drug.
There is one US patent protecting METACEL PHARMS LLC drugs.
Drugs and US Patents for Metacel Pharms Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Metacel Pharms Llc | OZOBAX DS | baclofen | SOLUTION;ORAL | 208193-002 | Oct 12, 2023 | AA | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ||||
| Metacel Pharms Llc | OZOBAX | baclofen | SOLUTION;ORAL | 208193-001 | Sep 18, 2019 | DISCN | Yes | No | 10,610,502 | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

